MIMOSA Diagnostics

📍 Toronto, Canada🗓 Founded 2016👥 36 employees💰 Last funded Jun 2024
MIMOSA: Making the invisible, visible. MIMOSA provides a proactive approach to skin health, allowing clinicians to implement earlier interventions, or even prevent them from being needed at all. Our products promote inclusive and equitable healthcare, enabling patients in remote areas and racialized people across the globe to access the critical health care everyone deserves.
3
Total investors
1
Early stage
0
Mid stage
2
Late stage
2016
Founded
Investor geography1 country
Canada
3
Investor activity2017–2024 · investors recorded per year
201712023120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in MIMOSA Diagnostics?
MIMOSA Diagnostics has 3 investors on record on gritt.io, including 1 early-stage backers and 2 late-stage investors.
When did MIMOSA Diagnostics last raise funding?
The most recent investment in MIMOSA Diagnostics recorded on gritt.io was in June 2024.
When was MIMOSA Diagnostics founded?
MIMOSA Diagnostics was founded in 2016.
What industry is MIMOSA Diagnostics in?
MIMOSA Diagnostics operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is MIMOSA Diagnostics based?
MIMOSA Diagnostics is headquartered in Toronto, Canada.